Grounds for Refusal and Cancellation of Sanitary Registration in Guatemala

1. Key takeaways

Guatemala keeps refusal of registration and cancellation of registration on two separate lists. Article 10 of NT 37 sets out four grounds for refusal (failure to meet the document requirements of Article 5, presence of prohibited or restricted materials, expired key certificates, and the product not belonging to the device category); Article 11 sets out four grounds for cancellation (the product proven harmful or unsafe, falsified or tampered documents, non-conformity with the quality controls set in the manufacturer’s specifications, and sale under conditions different from those approved). That makes eight grounds in total, plus the automatic cancellation provided in the note to Annex 2 when testing fails. Reading the two lists together gives a company the full map of how a registration can fail to be born or be taken away, and both maps point to controls that sit inside the company’s own documentation and change-management practices rather than in the authority’s discretion alone.

2. Legal basis

Basis: NT 37, Versión 5-2016 (2016-02-22), Articles 10 and 11 and Annex 2. On the reagent side, see NT-40, Article 5 (refusal of registration) and Article 6 (cancellation, comprising five items, 6.1 through 6.5).

3. Expert insights

Insight 1: Article 10.3 treats the expiry of three documents in parallel. The certificate of good manufacturing practice or manufacturing authorisation, the free sale certificate and the letter of authorisation are precisely the time-sensitive documents governed in detail by Article 5.2. Article 10.3, together with Article 5.2.2 (valid on the day of submission) and Article 5.2.6 (two years where no validity is stated), forms a complete chain of validity control. The practical consequence is that document validity is not a filing-week problem but a portfolio problem: each of these instruments expires on its own calendar, and a single lapsed certificate among them is enough to block the registration entirely under 10.3, however sound the rest of the dossier is.

Insight 2: Article 11.3 turns the specifications into a continuing constraint. One cancellation ground is non-conformity with the quality controls established in the manufacturer’s specifications, and the specifications are the very document submitted under Article 5.1.3. Registration materials remain citable enforcement evidence after the product reaches the market. The stricter the specifications are written, the larger the surface on which a later finding of non-conformity can be built. This does not argue for loose specifications, which would create their own risks, but for specifications drafted with realistic tolerances that manufacturing can actually hold, because the company will live inside what it declared for the life of the registration.

Insight 3: Article 11.4 and the change procedure of Article 6 are two sides of one coin. Selling under conditions different from those approved is a cancellation ground, and the lawful way to change conditions is the change procedure of Article 6. Altering packaging, specifications or the manufacturing plant without first filing the change does not trigger an administrative warning; it triggers the cancellation ground of Article 11.4. The two provisions together draw a bright line: change first, then implement. Any commercial pressure to ship first and file later runs directly across that line, and the consequence is not a correction but a potential loss of the registration itself.

Insight 4: The reagent side carries one additional cancellation ground. Article 6 of NT-40 lists five items, and the addition is Article 6.5, where the reagent is determined to have been altered (alterado). Article 2.7 defines alteration through four situations: ingredients substituted or added, changes in physicochemical, microbiological or functional properties, content deviating from the approved value, and improper storage not matching the product’s nature. Storage and transport conditions for reagents therefore connect directly to the survival of the registration, which makes cold-chain and handling controls a registration-maintenance issue rather than merely a quality preference.

Insight 5: The cancellation in the note to Annex 2 is automatic. Unlike the discretionary cancellations of Article 11, when the LNS testing conclusion is non-conformity the registration is cancelled automatically, and the market withdrawal period is only 15 days. There is no remediation window built into this mechanism; the only protection is upstream, in sample consistency and batch stability. Companies whose products are subject to testing should treat every retained sample as a potential arbitration of the registration’s fate and manage batch quality accordingly, because the administrative remedy does not exist.

4. Practical recommendations

• Build an expiry alert ledger for the three time-limited documents: the certificate of manufacturing assurance, the free sale certificate and the letter of authorisation.
• Draft finished-product specifications with reasonable tolerances so the company does not impose an unsustainable continuing constraint on itself.
• Route every change of conditions through the Article 6 change procedure before implementing it; never change the conditions of sale first.
• For reagent projects, additionally control storage and transport conditions so the product never falls into the alteration definitions of Article 2.7.
• Establish an emergency market-withdrawal procedure capable of execution within 15 days of a failed testing conclusion.

5. Verification checklist

• □ The four refusal grounds of Article 10 have been self-checked item by item
• □ The four cancellation grounds of Article 11 have been self-checked item by item
• □ Expiry alerts are in place for the three time-limited documents
• □ The tolerances in the finished-product specifications have been reviewed
• □ A change-before-implementation process is established for any change of conditions
• □ Storage and transport conditions for reagents are under control
• □ The 15-day emergency withdrawal procedure is in place

Regulatory information verified as of 29 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Guatemalan market. Our team manages Ministry of Public Health and Social Assistance (MSPAS) registrations, coordinates import and distributor requirements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com